TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Bioxytran Releases Details On A Novel Carbohydrate Galectin Inhibitor Designed To Eliminate COVID-19 In Patients

  • By GlobeNewswire
  • Mar 31, 2020 7:00 AM EDT
PRESS RELEASES

Bioxytran To Internally Develop Novel Carbohydrate Galectin Inhibitor To Eliminate COVID-19 In Patients

  • By GlobeNewswire
  • Mar 30, 2020 10:40 AM EDT
PRESS RELEASES

Bioxytran Licenses Novel Viral Inhibitor For COVID-19 Patients

  • By GlobeNewswire
  • Mar 24, 2020 8:48 AM EDT
PRESS RELEASES

Bioxytran Positioned To Detect And Treat Stroke And Neuropathologies

  • By GlobeNewswire
  • Feb 28, 2020 10:25 AM EST
PRESS RELEASES

Bioxytran Seeking Partners For Late Stage Treatment Of Wuhan Coronavirus Using BXT-25

  • By GlobeNewswire
  • Feb 5, 2020 7:00 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.